FindTrial
Sign In

The feasibility study of routine granular corneal dystrophy DNA screening before corneal refractive surgery

Prevalence of transforming growth factor b-induced gene corneal dystrophies in Q1 Chinese refractive surgery candidates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-SOC-17013813
Enrollment
Unknown
Registered
2017-12-14
Start date
2015-04-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ametropia, corneal refractive surgery

Interventions

surgery:corneal refractive surgery

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: From March 2015 to December 2016, the patients were diagnosed myopia and operated with corneal refractive surgery

Exclusion criteria

Exclusion criteria: 1. Other ophthalmopathy, such as cataract, glaucoma, etc.; 2. Systemic diseases such as asthma and heart disease.

Design outcomes

Primary

MeasureTime frame
TGF- ß;—

Secondary

MeasureTime frame
Anterior Corneal OCT;Slitlamp Biomicroscopy;corneal confocal;—

Countries

China

Contacts

Public ContactZhang Fengju

Beijing Tongren Hospital

zhangfj126@126.com+86 18601287753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026